The specific methods of immunotherapy in treatment of the patients with allergic seasonal rhinitis

E. B. Tiuleneva, O. V. Ershova (Moscow, Russia)

Source: Annual Congress 2002 - Specific immunotherapy in rhintis / inflammatory markers in exhaled air
Session: Specific immunotherapy in rhintis / inflammatory markers in exhaled air
Session type: Thematic Poster Session
Number: 3169
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. B. Tiuleneva, O. V. Ershova (Moscow, Russia). The specific methods of immunotherapy in treatment of the patients with allergic seasonal rhinitis. Eur Respir J 2002; 20: Suppl. 38, 3169

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

Cost-of-illness study of patients with allergic asthma and seasonal allergic rhinitis in Germany
Source: Eur Respir J 2001; 18: Suppl. 33, 399s
Year: 2001

Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Seasonal changes in patients with allergic rhinitis with or without asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 136s
Year: 2003

The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis
Source: Eur Respir J 2004; 24: 330
Year: 2004


Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008



Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003

Does treatment of allergic rhinitis with intranasal steroids improve asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 121s
Year: 2006

Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Omalizumab in the treatment of perennial allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 37s
Year: 2001

Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

Diagnosis and treatment of allergic rhinitis in asthmatic children
Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children
Year: 2009